SHAREHOLDER NOTICE:  Brodsky & Smith, LLC Announces an Investigation of Patheon N.V. – PTHN

BALA CYNWYD, June 23, 2017 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Patheon N.V. (“Patheon” or “the Company”) (NYSE – PTHN – News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thermo Fisher Scientific Inc. (“TMO”).

Under the terms of the transaction, Patheon shareholders will receive only $35.00 in cash for each share of Patheon stock they own. The investigation concerns whether the Board of Patheon breached their fiduciary duties to shareholders and whether TMO is underpaying for the Company. The transaction may undervalue the Company and may not be in the Patheon shareholders best interests.  For example, on June 8, 2017, the Company reported fiscal second-quarter profit of $27.6 million, results that exceeded Wall Street expectations and had the Company’s stock price moving in an upward trajectory.

If you own shares of Patheon stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, or calling toll  free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.